PRODUCT DETAIL

Marynarka 0,075 mg/0,020 mg tablety

Code

5517C

MA number

17/0025/17-S

Product Form:

tbl 63(3x21)x0,075 mg/0,020 mg (blis.PVC/PVDC/Al)

MA Status:

D - Marketing Authorisation valid for an unlimited period

Type of procedure:

Decentralised

Therapeutic Class:

17 - ANTICONCIPIENTIA

ATC:

G	GENITO URINARY SYSTEM AND SEX HORMONES
G03	SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM
G03A	HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
G03AA	Progestogens and estrogens, fixed combinations
G03AA10	Gestodene and ethinylestradiol(Gestodene and estrogen-delete WHO)

Shelf life:

Container:

blister PVC/PVDC/Al

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	19.10.2017
SPC:	SPC_Marynarka 0,075 mg_0,020 mg tablety_05.2023.pdf
PIL:	PIL_Marynarka 0,075 mg_0,020 mg tablety_05.2023.pdf
Safety feature	Yes
Data update:	14.08.2019